Thomas Axelsson, CEO of Vitrolife to Retire

More articles

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Thomas Axelsson, CEO of Vitrolife AB, informed the Board of Directors of his desire and intention to retire and be released from his position.

Consequently, the process to find a new CEO to replace Thomas Axelsson will immediately begin and will be led by Jon Sigurdsson, Chairman of the Board. Thomas will remain as the CEO until the recruitment process is finalized.

“Since Thomas joined as the CEO in 2011, he has achieved a remarkable value creation and profitable growth. His outstanding leadership and engagement have been essential for colleagues, partners customers, and shareholders. The Board and I want to thank Thomas for his contribution and aim to make the transition into a new leader for the Vitrolife Group as smooth as possible,” says Jon Sigurdsson.

“Ever since I entered Vitrolife, I have felt a strong passion for the dedicated difference we are making for people when we contribute to fulfilling their dream of having a baby. It has been a good journey together and while I will miss the dynamism of the business and all people involved, I have arrived at the conclusion that it is time for a new phase in life,” says Thomas Axelsson.

- Advertisement -spot_img

Latest